sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 01/11/2010
PIL Frumil LS

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/11/2010 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 18/08/2010 and displayed until 01/11/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 19/11/2009 and displayed until 18/08/2010
Reasons for adding or updating:
  • Change to drug interactions
Updated on 12/08/2008 and displayed until 19/11/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 29/04/2008 and displayed until 12/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 17/08/2006 and displayed until 29/04/2008
Reasons for adding or updating:
  • Change of licence holder
Updated on 20/09/2005 and displayed until 17/08/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   amiloride hydrochloride
   furosemide